HOPE in Action Prospective Multicenter Clinical Trial of HIV+ Deceased Donor Kidney Transplants for HIV+ Recipients
Brief description of study
Use of an HIV+ deceased donor could increase the risk of death, transplant-related or HIV-related complications; alternatively with effective antiretroviral treatment and careful HIV+ donor selection, these risks may be comparable to kidney transplant using an HIV-negative donor.
We hypothesize that receiving a kidney transplant from an HIV+ donor will be non-inferior to receiving a kidney transplant from an HIV-negative deceased donor.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
HIV, AIDS
-
Age: - 99 Years
-
Gender: All
Updated on
07 May 2021.
Study ID: 830023